Cyprotex (CRX)

 

Latest News

Cancellation - Cyprotex Plc

RNS Number: 8781R AIM 15 December 2016 NOTICE 15/12/2016 7:00am NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM CYPROTEX PLC At the request of the company trading on AIM for the under-mentioned securities has been cancelled from 15/12/2016 7:00am. ORDINARY SHARES OF 0.01 EACH, FULLY PAID (BP25RZ1)(GB00BP25R...

Scheme of Arrangement becomes effective

RNS Number: 8766R Cyprotex PLC 14 December 2016 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART), DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY RESTRICTED JURISDICTION (INCLUDING THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA AND NEW ZE...

Suspension - Cyprotex Plc

RNS Number: 7400R AIM 14 December 2016 NOTICE 14/12/2016 7:30am TEMPORARY SUSPENSION OF TRADING ON AIM CYPROTEX PLC At the request of the company trading on AIM for the under-mentioned securities has been temporarily suspended from 14/12/2016 7:30am, pending an announcement. ORDINARY SHARES OF 0.01 EACH, FULLY PAID ...

Director Dealing

RNS Number: 7514R Cyprotex PLC 13 December 2016 Cyprotex PLC ("Cyprotex" or "the Company") Director Dealing Cyprotex PLC (AIM: CRX), a specialist Contract Research Organisation, announces that it was notified on 12 December 2016 that, on 8 December 2016, John Dootson, Chief Financial Officer, transferred 36,000 ordinary shares of 1p each in the Compa...

All News

DateHeadlineSource
15-12-16Cancellation - Cyprotex PlcRNS
14-12-16Scheme of Arrangement becomes effectiveRNS
14-12-16Suspension - Cyprotex PlcRNS
13-12-16Director DealingRNS
13-12-16Court Sanction of Scheme of ArrangementRNS
09-12-16Form 8.5 (EPT/RI) Cyprotex PlcRNS
07-12-16Form 8.5 (EPT/RI) Cyprotex plcRNS
06-12-16Form 8.5 (EPT/RI) - Cyprotex PLCRNS
05-12-16Form 8.3 - Cyprotex PLCRNS
05-12-16Form 8.3 - Cyprotex PlcRNS
05-12-16Form 8.3 - Cyprotex PLCRNS
02-12-16Form 8.3 - Cyprotex PLCRNS
02-12-16Form 8.3 - Cyprotex PLCRNS
02-12-16Form 8.3 - Cyprotex PLCRNS
01-12-16Cyprotex-Evotec scheme of arrangement approvedStockMarketWire
01-12-16Results of Court Meeting & General MeetingRNS
01-12-16Form 8.5 (EPT/RI) - Cyprotex PLCRNS
01-12-16Form 8.3 - Cyprotex PLCRNS
30-11-16Form 8.5 (EPT/RI) Cyprotex PlcRNS
29-11-16Form 8.3 - CYPROTEX PLCRNS
29-11-16Form 8.5 (EPT/RI) Cyprotex PlcRNS
29-11-16Cyprotex launches in vitro h-CLAT serviceStockMarketWire
29-11-16Launch of in vitro h-CLAT ServiceRNS
28-11-16Form 8.3 - CYPROTEX PLCRNS
28-11-16Form 8.5 (EPT/RI) Cyprotex PlcRNS
25-11-16Form 8.5 (EPT/RI) Cyprotex plcRNS
23-11-16Form 8.5 (EPT/RI) Cyprotex PlcRNS
22-11-16Form 8.5 (EPT/RI) Cyprotex PlcRNS
21-11-16Form 8.5 (EPT/RI) Cyprotex PlcRNS
16-11-16Form 8.5 (EPT/RI) Cyprotex PlcRNS
15-11-16Form 8.5 (EPT/RI) Cyprotex PlcRNS
14-11-16Form 8.5 (EPT/RI) Cyprotex PlcRNS
11-11-16Director DealingRNS
10-11-16Form 8.5 (EPT/RI) Cyprotex PlcRNS
09-11-16Form 8.5 (EPT/RI) Cyprotex PlcRNS
08-11-16Form 8.5 (EPT/RI) Cyprotex PlcRNS
07-11-16Form 8.5 (EPT/RI) Cyprotex PlcRNS
04-11-16Posting of Scheme DocumentRNS
02-11-16Form 8.5 (EPT/RI) Cyprotex PlcRNS
01-11-16Form 8.5 (EPT/RI) CyprotexRNS

RSS feeds

  • Editorial news feed for LSE:CRX Editorial
  • Regulatory news feed for LSE:CRX Regulatory